Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Pre-Open Movers: Workday, Farfetch Gain on EPS; Seagen Falls on Deal Worries

Published 08/26/2022, 09:12 AM
Updated 08/26/2022, 09:14 AM
© Reuters.  Pre-Open Movers: Workday, Farfetch Gain on EPS; Seagen Falls on Deal Worries

Pre-Open Stock Movers:

Farfetch Limited (NYSE:FTCH) 17% HIGHER; reported Q2 EPS of ($0.17), $0.13 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $579.3 million versus the consensus estimate of $548.2 million.

Everbridge, Inc. (NASDAQ:EVBG) 15% HIGHER; the company is exploring a sale, Bloomberg reported.

Athersys, Inc. (Nasdaq: NASDAQ:ATHX) 13% LOWER; will be executing a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-25 after the close of trading on the Nasdaq Stock Market on Friday, August 26, 2022.

Workday (NASDAQ:WDAY) 10% HIGHER; reported Q2 EPS of $0.86, $0.07 better than the analyst estimate of $0.79. Revenue for the quarter came in at $1.54 billion versus the consensus estimate of $1.52 billion.

Affirm Holdings Inc (NASDAQ:AFRM10% LOWER; reported Q4 EPS of ($0.65), in-line with the analyst estimate of ($0.65). Revenue for the quarter came in at $364.1 million versus the consensus estimate of $354.66 million. Affirm Holdings sees Q1 2023 revenue of $345-365 million, versus the consensus of $386.02 million. Affirm Holdings sees FY2023 revenue of $1.625-1.725 million, versus the consensus of $1.91 million.

Seagen Inc (NASDAQ:SGEN) 7% LOWER; Merck & Company Inc (NYSE:MRK) takeover said to hit a snag over price.

Gap Inc (NYSE:GPS6% HIGHER; reported Q2 EPS of $0.08, $0.13 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $3.86 billion versus the consensus estimate of $3.82 billion. Given the actions the company has underway and in midst of a CEO transition, combined with the uncertain macro-environment, the company is withdrawing its prior fiscal 2022 outlook. The company is providing the following commentary related to its outlook for the remainder of fiscal 2022 and will share further details on its second quarter fiscal 2022 results conference call today at 2:00 pm Pacific Time.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Dell Technologies (NYSE:DELL) 5% LOWER; reported Q2 EPS of $1.68, $0.04 better than the analyst estimate of $1.64. Revenue for the quarter came in at $26.4 billion versus the consensus estimate of $26.61 billion.

MindMed (NASDAQ:MNMD) 5% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $3.50.

Elastic N.V. (NYSE:ESTC) 4% LOWER; reported Q1 EPS of ($0.15), $0.02 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $250.1 million versus the consensus estimate of $246.26 million. Elastic N.V. sees Q2 2023 EPS of ($0.11)-($0.09), versus the consensus of ($0.09). Elastic N.V. sees Q2 2023 revenue of $260-262 million, versus the consensus of $260.67 million. Elastic N.V. sees FY2023 EPS of ($0.31)-($0.25), versus the consensus of ($0.31). Elastic N.V. sees FY2023 revenue of $1.08-1.086 billion, versus the consensus of $1.08 billion.

Bed Bath & Beyond Inc. (NASDAQ:BBBY) 4% HIGHER; announced that, as previously stated, it will hold a conference call to provide a business and strategic update on August 31, 2022 at 8:15am EDT. A press release and related materials will be issued approximately 45 minutes prior to the start of the conference call.

Ulta Beauty (NASDAQ:ULTA) 3% HIGHER; reported Q2 EPS of $5.70, $0.80 better than the analyst estimate of $4.90. Revenue for the quarter came in at $2.3 billion versus the consensus estimate of $2.19 billion. Ulta Beauty sees FY2022 EPS of $20.70-$21.20, versus the consensus of $20.32. Ulta Beauty sees FY2022 revenue of $9.65-9.75 billion, versus the consensus of $9.53 billion.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.